April 25, 2022 at 2:54 pm
A new study finds that antidepressant drugs may not improve long-term quality of life. “If we don’t expect improvement from the continuous use of these medications, then the correct decision might be to stop the continuous use of these medications,” said Omar Almohammed, a pharmacologist at King Saud University in Saudi Arabia and a co-author of the study.
Read the full article at https://www.nytimes.com/2022/04/21/well/antidepressants-ssri-effectiveness.html
April 19, 2022 at 10:37 am
“Passengers on the Tube are routinely informed to “Mind the Gap” at each stop to help ensure a safe journey,” said MISSD founder Wendy Dolin. “Similarly, our train adverts spotlight a major healthcare gap so that patients can be better informed and safer. Most patients have never heard of akathisia, and some prescribers are unaware of the causes, symptoms, and potentially fatal risks.”
Read more about MISSD’s London Underground Awareness Campaign at https://www.einpresswire.com/article/568379273/new-adverts-on-the-london-underground-are-increasing-akathisia-awareness-to-reduce-suicide
April 14, 2022 at 2:27 pm
MISSD’s new akathisia awareness campaign on the London Underground is gathering attention from the press and fueling a Twitter storm. These ads are different from the MISSD ads that previously ran on Chicago, San Francisco and New York City trains. Tomorrow we’ll have more info about the reasons why.
Here’s an article published today in London’s newspaper, The Telegraph: https://www.telegraph.co.uk/search.html
April 7, 2022 at 11:48 am
“April is a month dedicated to raising awareness about important health issues,” said Dolin. It’s National Counseling Month, National Stress Awareness Month, and today is World Health Day. While MISSD works daily to increase awareness of akathisia, many health and suicide prevention organizations fail to discuss akathisia. Pharmaceutical ads that mention suicide “side effects” also neglect to communicate that these risks are frequently caused by akathisia. Such omissions increase the likelihood that psychiatric adverse drug effects are falsely attributed to life challenges or the consumer’s underlying condition and not to the pharmaceutical product.”
See MISSD’s press release at https://www.einpresswire.com/article/567162202/suicide-can-be-an-adverse-drug-effect
March 16, 2022 at 3:40 pm
Knowing the causes and symptoms of akathisia prior to starting, stopping, or changing dosage or type of certain medications can save lives. Had these families been in formed of the risks prior to receiving these prescriptions, they likely would never have had an akathisia story to share in our public health video. Listen and learn at https://www.youtube.com/watch?v=ibCOhnmM608
March 1, 2022 at 12:01 pm
A new study finds clinicians need withdrawal guidance and training to better ensure patients can safely discontinue these drugs. When SSRI withdrawal and withdrawal akathisia is misdiagnosed as relapse, consumers are more likely to continue taking risky drugs they do not need.
Read the full article at https://www.madinamerica.com/2022/02/official-guidelines-antidepressant-discontinuation-fail-practitioners-patients/